Einsatz von G-CSF (Neupogen®) bei multimodalen Therapiekonzepten in der Strahlentherapie

Abstract

When a decrease of leucocyte values lower than 1000/mm3 is expected, the most cost-effective treatment is given when starting the interventional G-CSF administration already at leucocyte values around 1600/mm3. Leucopenias can be treated effectively, with little side effects and in a cost-effective way when G-CSF is given on time.